[1]
H. DAOUDI, S. EL MARNISSI, Y. BOUSLIMAN, S. SERRAGUI, and M. AIT EL CADI, “Chemotherapy administration-related adverse events and their impact on patient management: the case of Rituximab”, jmrhs, vol. 6, no. 5, pp. 2584–2589, May 2023.